News
Eli Lilly to Present New Oncology Data at ESMO Congress 2026
Eli Lilly’s oncology pipeline will feature at ESMO Congress 2026, with data presentations on investigational sofetabart mipitecan and olomorasib, alongside updated findings for Retevmo (selpercatinib) and Verzenio (abemaciclib).


